Marco Tripodi

Publications

Title Published on Year
HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2024
Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 2024
m6A modification inhibits miRNAs’ intracellular function, favoring their extracellular export for intercellular communication CELL REPORTS 2024
Extracellular signal-Regulated Kinase 5 (ERK5) is required for the Yes-associated protein (YAP) co-transcriptional activity CELL DEATH & DISEASE 2023
Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective CELL & BIOSCIENCE 2023
Extracellular signal-Regulated Kinase 5 (ERK5) is required for the Yes-associated protein (YAP) co-transcriptional activity CELL DEATH & DISEASE 2023
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells JOURNAL OF MEDICINAL CHEMISTRY 2023
HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 2023
SYNCRIP Modulates the Epithelial-Mesenchymal Transition in Hepatocytes and HCC Cells INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Next RNA therapeutics: the mine of non-coding INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells CELL DEATH & DISEASE 2022
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2022
Persistence of fibrogenic process in direct-acting antiviral (DAA) treated patients? EXRNA 2022
lncRNA HOTAIR functions and therapeutic perspectives ONCOSCIENCE 2022
Mechanisms of peritoneal fibrosis: focus on immune cells-peritoneal stroma interactions FRONTIERS IN IMMUNOLOGY 2021
Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response JOURNAL OF HEPATOLOGY 2021
The RNA editing enzyme ADAR2 restricts L1 mobility RNA BIOLOGY 2021
Pleural mesothelial cells modulate the inflammatory/profibrotic response during SARS-CoV-2 infection FRONTIERS IN MOLECULAR BIOSCIENCES 2021
A novel RNA-based approach to counteract EMT ONCOSCIENCE 2021
Novel quinoline compounds active in cancer cells through coupled DNA methyltransferase inhibition and degradation CANCERS 2020

ERC

  • LS1
  • LS1_1
  • LS1_3
  • LS2_3
  • LS2_4
  • LS2_8
  • LS3_5
  • LS4_12

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Keywords

EMT Epithelial-Mesenchymal Transition
long non-coding RNA (lncRNA)
miRNA
RNA-protein interactions
epigenetic

Laboratori di ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma